Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Next-generation humanized patient-derived xenograft mouse model for pre-clinical antibody studies in neuroblastoma

11 Sept 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Immune Cell Function and Interaction
Share to Neuroblastoma Research and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32915319
DOI: 10.1007/s00262-020-02713-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Next-generation humanized patient-derived xenograft mouse model for pre-clinical antibody studies in neuroblastomaPMID 32915319Read ↗

Pharmacokinetics of human-mouse chimeric anti-GD2 mAb ch14.18 in a phase I trial in neuroblastoma patientsSemantic proximity Read ↗

Challenges and Prospects of Patient-Derived Xenografts for Cancer ResearchSemantic proximity Read ↗

Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer ResearchSemantic proximity Read ↗

A fast and efficient model for real-time anti-tumor drug efficacy test in the clinical setting based on patient-derived tumor xenograftSemantic proximity Read ↗

Retrospective analysis of the preparation and application of immunotherapy in cancer treatment (Review)Semantic proximity Read ↗

The 5TMM series: a useful in vivo mouse model of human multiple myelomaSemantic proximity Read ↗

From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic miceSemantic proximity Read ↗

Development of Clinical-Grade Antibodies against Tumor-Specific Mutations to Target Neuroblastoma.Semantic proximity Read ↗

Antibody discovery: the use of transgenic mice to generate human monoclonal antibodies for therapeuticsSemantic proximity Read ↗

Clinical Potential of Antibody–Drug Conjugates in Early-Phase Clinical Trials for Late-Line Treatment of Advanced Solid TumorsSemantic proximity Read ↗

Human cancer xenografts in immunocompromised mice provide an advanced genuine tumor model for research and drug development-A revisit of murine models for human cancersSemantic proximity Read ↗

Application of Highly Immunocompromised Mice for Establishment of Patient-Derived Xenograft (PDX) ModelSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.